Through
1/1
A Penn Medicine study finds that combining remdesivir or molnupiravir with the experimental drug brequinar blocked the replication of the virus that causes COVID-19 in lung cells.
A Penn LDI and Penn Population Aging Research Center team tracks behavior and attitudes in Malawi during COVID-19’s first wave.
Tiffany Tieu led a study on the psychology of mask-wearing and its relationship with a person’s moral values, using Penn undergraduates as the subjects.
The Perelman School of Medicine’s Frederic Bushman and Susan Weiss share what they and other scientists are learning about the new, dominant variant of SARS-CoV-2.
How decades of mRNA research at Penn made powerful new COVID-19 vaccines possible—and opened a new vista for future discoveries.
Millions continue to believe misinformation about vaccination and COVID-19, and these beliefs are associated with hesitancy to get themselves and their children vaccinated—or, if they are vaccinated, to get a booster for added protection.
By comparing and contrasting the two nations’ approaches to controlling infectious diseases, students in Parallel Plagues deepened their appreciation of how these diseases emerge, cause harm, and might be effectively controlled.
In a conversation hosted by LDI, experts from Penn, the Black Doctors COVID-19 Consortium, and the Coalition for Epidemic Preparedness Innovations discussed the vaccine rollout, boosters, misinformation, and more.
Researchers can’t yet pinpoint definitive reasons, though they surmise it was a combination of factors, including stress, an outsized focus on weight gain and personal appearance, and maybe even symptoms of COVID-19 itself.
An analysis of hospital care for COVID-19 patients shows that while short hospitalizations were often unavoidable, it is be possible to expedite the discharge for patients who could continue to recover at home, with some additional clinical support from the health system.
Penn is lauded for its research and development efforts, including the modified mRNA technique that was commercialized into a COVID vaccine and won its researchers a Nobel Prize last year.
FULL STORY →
Ken Cadwell of the Perelman School of Medicine studies how COVID affects the gut and explains you will feel the illness in other parts of your body and not just your lungs.
FULL STORY →
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →